The US-based supplier of access and procedure products, Galt Medical, has acquired Arrotek, a Sligo based company that specialises in the design and development of new medical device products.
Arrotek was founded in 2005 by Mark Pugh and Ger O’Carroll. It specialises in designing minimally invasive medical devices. It is based in Collooney in Sligo and is currently building a new state-of-the-art facility in Finisklin, Sligo.
Arrotek is a founding member of the Atlantic MedTech Cluster. Find out more about Arrotek by visiting its website.
Galt Medical’s headquarters is in Texas. For the past 30 years, it has been providing vascular and interventional medical devices to customers all over the world. In addition to its facilities in Texas, it also has facilities in Massachusetts and Costa Rica.
Arrotek’s founders will remain with the company as co-Managing Directors.
Mark Pugh said: “Galt provides Arrotek with access to markets, capabilities, and expertise previously unavailable to us. The combination with Galt will benefit existing customers of both companies, as well as providing Arrotek with opportunities to serve new segments of the market in Europe, North America, and other global markets.
“Becoming part of the larger Theragenics organisation also provides the resources to accelerate our growth and continue to expand.”
Frank Attardo, President of Galt Medical, said: “The capabilities of Arrotek and Galt are highly complementary to each other. Arrotek’s product development capabilities, combined with Galt’s manufacturing and processing capabilities, will allow the combined company to better serve existing customers and address and serve a wider segment of the interventional market.”